Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors
Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Dermatology Clinical Summary Source Type: news
More News: Cancer & Oncology | Carcinoma | Dermatology | Hematology | Skin | Squamous Cell Carcinoma